Navigation Links
Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
Date:10/13/2009

CARLSBAD, Calif., Oct. 13 /PRNewswire/ -- Luminous Medical, Inc. announced today that it has reached agreement with a major supplier of electrochemical sensors for exclusive rights to incorporate its glucose sensor into Luminous' automated blood glucose monitor. Luminous is developing its monitor to enable clinicians to control hyperglycemia in critical care patients around the world.

Previously, Luminous was planning to use a sensing technology based on near-infrared spectrometry. "More than a year ago we realized that it was going to be difficult to gain FDA clearance for any novel glucose technology for use in the critical care environment," said Richard Thompson, president and CEO of Luminous Medical. "Our new approach uses standard, calibratable glucose oxidase chemistry with which the agency is very familiar."

Luminous has already incorporated the glucose oxidase sensing technology into its design and is preparing for pivotal clinical trials and a 510k application in 2010. "We were fortunate that we could modify our product to accept the new sensing technology," said Bill Patterson, Vice President of R&D. "The sensor is already being used in a product that has been cleared by the FDA to measure glucose in the ICU, which makes our development process straightforward."

Glucose oxidase electrochemistry has been used to measure glucose with near laboratory accuracy in point of care devices for many years. The FDA has recently expressed concern about the use of test strip based glucose meters that are not cleared to manage glucose in hospitalized patients. The Luminous product is being designed to automate the process of glucose monitoring while simultaneously raising the bar for measurement accuracy at the point of care.

About Luminous Medical, Inc.:

Luminous is developing an automated blood glucose monitor to address the strong clinical demand for glycemic control. Multiple clinical studies have demonstrated significant morbidity and mortality benefits from controlling glucose levels in critical care patients. As a result, clinicians have rapidly adopted glycemic control procedures but struggle with inadequate and time consuming manual methods. The Luminous monitor is being designed to automate these glycemic control procedures.

Luminous will be displaying its automated blood glucose monitor at the Society of Critical Care Medicine's Post-Congress Conference to be held in Key West, Florida from January 13th - January 15th, 2010. The product has not been cleared for use by the FDA. More information is available at www.luminousmedical.com.

SOURCE Luminous Medical, Inc.


'/>"/>
SOURCE Luminous Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
2. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
3. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
4. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
5. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
6. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
7. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
8. GeoVax Secures $10 Million Financing Commitment
9. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
10. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
11. ALung Secures $2.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
Breaking Medicine News(10 mins):